Cicatrizing conjunctivitis.
D000328:Adult; D000368:Aged; D002057:Burns, Chemical / Q000150:complications; D002921:Cicatrix / Q000209:etiology*; D003228:Conjunctiva / Q000528:radiation effects; D003231:Conjunctivitis / Q000209:etiology* / Q000276:immunology; D003874:Dermatitis Herpetiformis / Q000150:complications; D004837:Epinephrine / Q000009:adverse effects; D004892:Erythema Multiforme / Q000150:complications; D005126:Eye Burns / Q000139:chemically induced; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications; D006145:Guanethidine / Q000009:adverse effects; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D006967:Hypersensitivity; D007136:Immunoglobulins / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010390:Pemphigoid, Benign Mucous Membrane / Q000150:complications; D011217:Practolol / Q000009:adverse effects; D014141:Trachoma / Q000150:complications
D006680:HLA Antigens; D007136:Immunoglobulins; D011217:Practolol; D004837:Epinephrine; D006145:Guanethidine